Montag A & Associates Inc. decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 10.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,230 shares of the healthcare conglomerate's stock after selling 1,166 shares during the quarter. Montag A & Associates Inc.'s holdings in UnitedHealth Group were worth $5,358,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Citizens National Bank Trust Department grew its holdings in UnitedHealth Group by 1.0% during the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after buying an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH grew its holdings in UnitedHealth Group by 0.3% during the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock worth $277,641,000 after buying an additional 1,465 shares in the last quarter. Sherbrooke Park Advisers LLC bought a new stake in UnitedHealth Group during the fourth quarter worth $515,000. Full Sail Capital LLC grew its stake in UnitedHealth Group by 2.1% in the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after purchasing an additional 33 shares during the period. Finally, Soros Fund Management LLC bought a new position in UnitedHealth Group in the 4th quarter valued at $39,413,000. Institutional investors own 87.86% of the company's stock.
Insiders Place Their Bets
In other news, Director Kristen Gil bought 3,700 shares of the firm's stock in a transaction that occurred on Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the transaction, the director owned 3,818 shares of the company's stock, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Timothy Patrick Flynn bought 1,533 shares of the firm's stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director directly owned 6,033 shares of the company's stock, valued at $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company's stock.
UnitedHealth Group Stock Performance
Shares of UNH opened at $282.45 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The firm has a market capitalization of $256.22 billion, a P/E ratio of 11.83, a PEG ratio of 1.38 and a beta of 0.45. The business has a fifty day moving average of $304.47 and a 200 day moving average of $432.89.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the firm posted $6.91 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 3.13%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. UnitedHealth Group's payout ratio is presently 37.02%.
Wall Street Analysts Forecast Growth
A number of brokerages have recently commented on UNH. Baird R W cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, June 11th. Royal Bank Of Canada dropped their price target on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. Bank of America cut UnitedHealth Group from a "buy" rating to a "neutral" rating and dropped their price objective for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. Robert W. Baird cut UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price objective on the stock. in a report on Wednesday, June 11th. Finally, UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a report on Thursday. One analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus target price of $394.43.
Read Our Latest Analysis on UNH
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report